Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.14ac08982DOI Listing

Publication Analysis

Top Keywords

endocannabinoid system
4
system schizophrenia
4
schizophrenia links
4
links underlying
4
underlying pathophysiology
4
pathophysiology novel
4
novel treatment
4
treatment approaches
4
endocannabinoid
1
schizophrenia
1

Similar Publications

Emerging pharmacological strategies for the treatment of cannabis use disorder.

Expert Opin Pharmacother

September 2025

Department of Psychiatry, University of Calgary, Calgary, Alberta.

Introduction: Cannabis use disorder (CUD) is a growing global health concern, with limited pharmacological treatments currently available despite increasing prevalence and legalization trends.

Areas Covered: This review explores the landscape of pharmacotherapies for CUD, including both repurposed agents and emerging investigational compounds. We summarize findings from recent systematic reviews and meta-analyses, with attention to mechanisms of action and clinical relevance.

View Article and Find Full Text PDF

Objective: To investigate the neural and molecular correlates of occupational burnout in nurses by integrating resting-state fMRI (rs-fMRI), clinical assessments, brain-wide gene expression, and neurotransmitter atlases.

Methods: Fifty-one female nurses meeting burnout criteria and 51 matched healthy controls underwent 3 T rs-fMRI. We analyzed fractional amplitude of low-frequency fluctuations (fALFF) and seed-based functional connectivity (FC), correlating findings with burnout (emotional exhaustion [EE], depersonalization [DP], and personal accomplishment [PA]).

View Article and Find Full Text PDF

Exogenous cannabinoids have long been known to promote eating. However, the underlying mechanisms have not been completely elucidated, which is critical to understanding their utility. The orexin/hypocretin (OH) system of the lateral hypothalamus (LHA) has known anatomical, biochemical, and physiological interactions with the endocannabinoid system, and has an established role in promoting appetitive behavior; yet, it is still unknown if the OH system mediates food intake following cannabinoid administration.

View Article and Find Full Text PDF

The endocannabinoid (eCB) system-comprising cannabinoid receptors, eCBs (anandamide- AEA, 2-arachidonoylglycerol-2-AG) and related -acylethanolamines (NAEs; palmitoylethanolamide-PEA, and oleoylethanolamide-OEA), and metabolizing enzymes (e.g., fatty acid amide hydrolase; FAAH)-modulates nociceptive circuits in rodents.

View Article and Find Full Text PDF